| Literature DB >> 29249563 |
Zonghua Luo1, Xuyi Yue1, Hao Yang1, Hui Liu1, Robyn S Klein2, Zhude Tu3.
Abstract
Eleven new sphingosine 1-phosphate receptor 2 (S1PR2) ligands were synthesized by modifying lead compound N-(2,6-dichloropyridin-4-yl)-2-(4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)hydrazine-1-carboxamide (JTE-013) and their binding affinities toward S1PRs were determined in vitro using [32P]S1P and cell membranes expressing recombinant human S1PRs. Among these ligands, 35a (IC50 = 29.1 ± 2.6 nM) and 35b (IC50 = 56.5 ± 4.0 nM) exhibit binding potency toward S1PR2 comparable to JTE-013 (IC50 = 58.4 ± 7.4 nM) with good selectivity for S1PR2 over the other S1PRs (IC50 > 1000 nM). Further optimization of these analogues may identify additional and more potent and selective compounds targeting S1PR2.Entities:
Keywords: Binding affinities; Multiple sclerosis; Selectivity; Sphingosine 1-phosphate receptor 2
Mesh:
Substances:
Year: 2017 PMID: 29249563 PMCID: PMC8781228 DOI: 10.1016/j.bmcl.2017.12.010
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823